United States· US:17772-132_5b89031c-41a3-d7e0-e063-6294a90af6fb
QELBREE
A viloxazine product containing viloxazine hydrochloride, registered in United States by Supernus Pharmaceuticals, Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VILOXAZINE HYDROCHLORIDE
- Manufacturer
- Supernus Pharmaceuticals, Inc
- Country
- United States (US)
- ATC code
- N06AX09
- ATC class
- Viloxazine
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 5
- ndc1117772-132-07
- ndc1117772-132-30
- ndc1117772-132-60
- ndc1117772-132-90
- ndc1117772-132-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N06AX09
Viloxazine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/34c80112-ad76-4156-91e8-c4befa1893b0 GET /v1/drugs/34c80112-ad76-4156-91e8-c4befa1893b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "150",
"substance": "VILOXAZINE HYDROCHLORIDE",
"productndc": "17772-132",
"dosage_form": "CAPSULE, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA211964",
"marketing_category": "NDA"
}See everything about viloxazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.